MRI/Ultrasound Fusion Guided Prostate Cryotherapy
Launched by UROLOGICAL RESEARCH NETWORK, LLC · Mar 5, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to treat prostate cancer using a method called cryotherapy, which involves freezing cancer cells to destroy them. The treatment is guided by advanced imaging techniques, including MRI and ultrasound, to ensure that the cancerous areas identified by a biopsy are precisely targeted. The main goal is to see how well this treatment controls the cancer over five years while minimizing any negative effects on the patients' quality of life.
Men aged 55 to 65 with low to intermediate risk prostate cancer, or men over 65 with certain conditions, may be eligible to participate. To qualify, they should have specific characteristics such as a low percentage of positive biopsy results and no signs of advanced cancer spreading beyond the prostate. Participants in this trial can expect to receive focused treatment aimed at eradicating the cancer while being carefully monitored to ensure their overall well-being. This trial is currently recruiting participants, and it's a promising step toward better prostate cancer care.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Men between 55 and 65 years of age with a clinical diagnosis of prostate cancer with Low or Intermediate risk prostate cancer, and \<50% positive core rate by prostate lobe
- • Men older than 65 years of age with clinical diagnosis of prostate cancer \<50% positive core rate by prostate lobe
- • Absence of extra-capsular extension
- • Absence of seminal vesicle invasion
- • Absence of regional or distant metastatic disease
- • Multiparametric MRI of the prostate performed either before the biopsy or \>10 weeks after prostate biopsy
- • Treated with Cryotherapy of the prostate
- • Treatment based on co-registration between MP-MRI and Prostate Ultrasound
- Exclusion Criteria:
- • Prior treatment of prostate cancer in the form of surgery.
- • Performance status greater than 0 based on ECOG criteria
- • Mental status impairment
About Urological Research Network, Llc
Urological Research Network, LLC is a dedicated clinical trial sponsor specializing in advancing innovative treatments and therapies for urological conditions. With a robust commitment to improving patient outcomes, the organization collaborates with leading researchers, healthcare providers, and industry partners to conduct rigorous clinical studies. By leveraging state-of-the-art methodologies and a patient-centered approach, Urological Research Network aims to enhance the understanding of urological diseases and facilitate the development of groundbreaking solutions that address unmet medical needs in this vital field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami Lakes, Florida, United States
Patients applied
Trial Officials
FERNANDO J BIANCO, MD
Principal Investigator
UROLOGICAL RESEARCH NETWORK
EUSEBIO LUNA, MD
Study Director
UROLOGICAL RESEARCH NETWORK
Isabel H Lopez, MD
Study Director
UROLOGICAL RESEARCH NETWORK
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials